Needham & Co. upgrades Celldex Therapeutics Inc. (Nasdaq: CLDX) from Hold to Buy with a $14 price target saying they ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE